University of Texas at Austin
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Texas at Austin sits in the top decile of US sponsors by registered trial count (#129 of 15,742 sponsors by registered trial count).
University of Texas at Austin: 257 sponsored US clinical trials, 59 recruiting.
University of Texas at Austin sponsors 257 registered US clinical trials on ClinicalTrials.gov, 59 of them currently recruiting, and 160 completed. 13 of these trials are in Phase 3-4 (later-stage) and 22 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Post Traumatic Stress Disorder, with 8 trials.
Top-decile sponsor footprint
University of Texas at Austin ranks in the top decile of sponsors by registered trial count (#129 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
160 of 169 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (94.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
257 total, page 2 of 6
CHOICES-TEEN Randomized Controlled Trial
NCT05368571
Neurocognitive Effects of Non-Invasive Near-Infrared Light Stimulation
NCT05802680
Integrated Tele-Behavioral Activation and Fall Prevention for Low-income Homebound Seniors With Depression
NCT05011864
Effect of Acute Nitrate Supplementation on Vascular Function in Hispanic, Black and White Population
NCT05188079
Non-invasive BCI-controlled Assistive Devices
NCT05183152
Registry and Biorepository for IBD in Central Texas
NCT04617184
Empowering Students Project
NCT05511298
Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's Disease
NCT03082755
Exploring the Nature, Assessment and Treatment of Stuttering
NCT05908123
Testing a Brief Reassurance Message Before a Musculoskeletal Clinic Visit
NCT07330492
Wearable Focused Ultrasound Stimulation for Peripheral Nerve Pain Management
NCT07160049
Testing an AI Large Language Model Tool for Cognitive Debiasing in Musculoskeletal Care
NCT07022769
Supportive Outcomes Through Listening, Validation, and Empowerment
NCT06587594
Evaluating the Efficacy of Voice Therapy for Neurogenic Voice Disorders
NCT07474740
Cognitive Screening Made Easy for PCPs - R33 Phase
NCT06162026
Hypertonic Saline for Mild TBI in Pediatric Patients
NCT07060105
Video-Assisted Informed Consent for Neonatal Lumbar Puncture
NCT07074925
Impact of an Enhanced Patient Reported Outcome Measurement (PROM) Strategy on PROM Completion Rates
NCT06078137
Project Sueño: Sleep & Understanding Early Nutrition in Obesity
NCT06117631
Evaluating the Impacts of a Well-Being Mobile App in Mexico
NCT07109648
A Randomized Controlled Trial of Miles de Manos (Thousands of Hands)
NCT05932056
Optimizing Intervention Options for Toddlers With Early Social Communication Delays
NCT05307094
Focused Ultrasound Amygdala Neuromodulation
NCT05228964
A Coping Skills Program for Children With Asthma
NCT05118282
Rebreathing-induced Hypoxia and Glucose Levels
NCT05422430
Efficacy of the ASPEN Intervention Program in Low-Resource Communities
NCT04505488
Resilience-Based Diabetes Self-Management Education (RB-DSME) for African Americans
NCT04282395
Mothers And careGivers Investing in Children
NCT04177472
Treatment for Speech and Language in Primary Progressive Aphasia
NCT04881617
Suzetrigine for Opioid-Free Recovery After Cesarean Delivery
NCT07534709
Pressure Targeting During High Flow Therapy in Premature Infants
NCT07418502
Neurocircuitry Mechanisms and Efficacy of Lumateperone as Adjunctive Therapy for Major Depressive Disorder and History of Early Life Abuse
NCT07369115
Brain State-dependent PCMS in Chronic Stroke
NCT04830163
Injection Ports vs Single-Use Needles for Insulin in Pregnancy: Effects on Adherence and Satisfaction
NCT07165327
Understanding Patient Preferences When Deciding on a Voluntary Musculoskeletal Test
NCT07158892
Wearable Neural Interfacing System for REM Sleep Restoration and Enhancement
NCT07190287
Evaluating the Neuromodulatory Effect of Ketamine in Long COVID-19
NCT06821087
Leggings With Resistance Bands on Caloric Expenditure During Exercise
NCT06547060
A Controlled Breathing Intervention to Reduce Stress and Improve Symptoms in COPD Patients (REST)
NCT06404008
Storytelling Through Music to Improve Well-being Among Homeless Service Providers
NCT06536387
TACAD Program for Asian American Family Caregivers of Persons Living With Alzheimer's Disease
NCT05615233
Duration of Physical Inactivity and Postprandial Lipid Metabolism
NCT06407050
Talking Circle for Native American Youth
NCT06781736
Measuring and Displaying the Subjective
NCT06490224
Adaptations to 4-s Sprint Interval Training at Different Intensities
NCT06906393
Evaluation of Nutrition Training Augmented With Digital Technology in Graduate Medical Education
NCT06088251
Study of Nutrition in Postpartum and Early Life Feeding Study
NCT06082921
Inactivity Duration on Lipid Metabolism
NCT06033898
Dialysis CHW Pilot
NCT05998850
'Food, Fun, Fresh, Family' Program for Healthy Eating and Growth for Elementary-age Children.
NCT06010784
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 16 |
| Phase 2 | 6 |
| Phase 3 | 5 |
| Phase 4 | 8 |
What is open in the University of Texas at Austin pipeline
59 recruiting of 257 indexed (23% open); 160 completed (62%).
Phase mix: 13 late (III/IV) vs 22 early (I/II) (early-phase heavy).
Top condition: Post Traumatic Stress Disorder (8 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Texas at Austin: open-pipeline peers nationwide
Peers matched on 257 registered trials and 23% open enrollment, not the therapeutic-area sidebar.
University of Texas at Austin sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 257 trials (± recruiting share)
- Pennington Biomedical Research Center · 258 trials · 13% recruiting
- Abbott Medical Devices · 261 trials · 9% recruiting
- Boston Medical Center · 253 trials · 11% recruiting
- University of South Florida · 252 trials · 17% recruiting
Sponsors near 23% open enrollment (± trial volume)
- Icahn School of Medicine at Mount Sinai · 23% recruiting · 708 trials
- Veterans Medical Research Foundation · 23% recruiting · 35 trials
- Clemson University · 23% recruiting · 13 trials
- Liberating Technologies · 23% recruiting · 13 trials
Related
What to do with this University of Texas at Austin page
257 registered trials is a research-attention snapshot, not an endorsement of University of Texas at Austin or any single study.
- 59 of University of Texas at Austin's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Post Traumatic Stress Disorder is the condition University of Texas at Austin studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Post Traumatic Stress Disorder trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Texas at Austin pipeline card: 257 registered trials from official public datasets.Report a data error.